Feeder-independent culture of human embryonic stem cells
The DOI matches its Crossref record; 16 of the 17 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Since the discovery of iPSC generation, the field has transitioned from using PSC culture media containing animal reagents to Xeno-free and even animal-free media [64,65,66].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [65]
Citations
Cites
Amit, M., Carpenter, M. K., Inokuma, M. S., Chiu, C.-P., Harris, C. P., Waknitz, M. A., Itskovitz-Eldor, J., & Thomson, J. A. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9912 · Cited by 1,472
Derivation of human embryonic stem cells in defined conditions
Ludwig, T. E., Levenstein, M. E., Jones, J. M., Berggren, W. T., Mitchen, E. R., Frane, J. L., Crandall, L. J., Daigh, C. A., Conard, K. R., Piekarczyk, M. S., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1177 · Cited by 1,114 · cited 1×
“, and based on inhibitor studies, it has been suggested that TGFβ/activin signaling is essential for human embryonic stem cell self-renewa”
BackgroundSelf-citationRecurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., Meisner, L., Zwaka, T. P., Thomson, J. A., & Andrews, P. W. (2004) · Nature Biotechnology · doi:10.1038/nbt922 · Cited by 1,021
Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells
Xu, R.-H., Peck, R. M., Li, D. S., Feng, X., Ludwig, T., & Thomson, J. A. (2005) · Nature Methods · doi:10.1038/nmeth744 · Cited by 973
James, D., Levine, A. J., Besser, D., & Hemmati-Brivanlou, A. (2005) · Development · doi:10.1242/dev.01706 · Cited by 896
Feeder Layer- and Serum-Free Culture of Human Embryonic Stem Cells1
Amit, M., Shariki, C., Margulets, V., & Itskovitz-Eldor, J. (2004) · Biology of Reproduction · doi:10.1095/biolreprod.103.021147 · Cited by 664
Activin A Maintains Pluripotency of Human Embryonic Stem Cells in the Absence of Feeder Layers
Beattie, G. M., Lopez, A. D., Bucay, N., Hinton, A., Firpo, M. T., King, C. C., & Hayek, A. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0279 · Cited by 503
Basic Fibroblast Growth Factor Support of Human Embryonic Stem Cell Self-Renewal
Levenstein, M. E., Ludwig, T. E., Xu, R.-H., Llanas, R. A., VanDenHeuvel-Kramer, K., Manning, D., & Thomson, J. A. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0247 · Cited by 456
Xu, C., Rosler, E., Jiang, J., Lebkowski, J. S., Gold, J. D., O'Sullivan, C., Delavan‐Boorsma, K., Mok, M., Bronstein, A., & Carpenter, M. K. (2005) · STEM CELLS · doi:10.1634/stemcells.2004-0211 · Cited by 418
Vallier, L., Reynolds, D., & Pedersen, R. A. (2004) · Developmental Biology · doi:10.1016/j.ydbio.2004.08.031 · Cited by 350
Research works printed but not linked: 1
- Mather, J., Kaczarowski, F., Gabler, R. & Wilkins, F. Effects of water purity and addition of common water contaminants on the growth of cells in serum-free media. Biotechniques 4, 56–63 (1986).
Cited by
Items 201–300 of 684
An apicosome initiates self-organizing morphogenesis of human pluripotent stem cells
Taniguchi, K., Shao, Y., Townshend, R. F., Cortez, C. L., Harris, C. E., Meshinchi, S., Kalantry, S., Fu, J., O’Shea, K. S., & Gumucio, D. L. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201704085 · Cited by 47
Functional and Sustainable 3D Human Neural Network Models from Pluripotent Stem Cells
Cantley, W. L., Du, C., Lomoio, S., DePalma, T. J., Peirent, E. R., Kleinknecht, D., Hunter, M., Tang‐Schomer, M. D., Tesco, G., & Kaplan, D. L. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00622 · Cited by 48
“The hiPSCs were generated as described (ND41866(18), GM24666(19), ND35367(20), YZ1(21)) and were maintained in feeder free conditions as previously described(22).”
MethodA distinct isoform of ZNF207 controls self-renewal and pluripotency of human embryonic stem cells
Fang, F., Xia, N., Angulo, B., Carey, J., Cady, Z., Durruthy-Durruthy, J., Stoddard-Bennett, T., Sebastiano, V., & Pera, R. A. R. (2018) · Nature Communications · doi:10.1038/s41467-018-06908-5 · Cited by 50
Human Pluripotency Is Initiated and Preserved by a Unique Subset of Founder Cells
Nakanishi, M., Mitchell, R. R., Benoit, Y. D., Orlando, L., Reid, J. C., Shimada, K., Davidson, K. C., Shapovalova, Z., Collins, T. J., Nagy, A., et al. (2019) · Cell · doi:10.1016/j.cell.2019.03.013 · Cited by 51
Development of serum-free culture systems for human embryonic stem cells
Chase, L. G., & Firpo, M. T. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.06.421 · Cited by 50
Efficient and safe single-cell cloning of human pluripotent stem cells using the CEPT cocktail
Tristan, C. A., Hong, H., Jethmalani, Y., Chen, Y., Weber, C., Chu, P.-H., Ryu, S., Jovanovic, V. M., Hur, I., Voss, T. C., et al. (2023) · Nature Protocols · doi:10.1038/s41596-022-00753-z · Cited by 44
Pagliaro, A., Finger, R., Zoutendijk, I., Bunschuh, S., Clevers, H. C., Hendriks, D. F. G., & Artegiani, B. (2023) · Nature Communications · doi:10.1038/s41467-023-43141-1 · Cited by 58
“TGF-β is necessary for the maintenance of stem cell pluripotency 45,46,65,66 , whichultimately in fl uences the formation of optimal telencephalic rosettes 67 .”
Levenstein, M. E., Berggren, W. T., Lee, J., Conard, K. R., Llanas, R. A., Wagner, R. J., Smith, L. M., & Thomson, J. A. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1056 · Cited by 46
Polymeric Biomaterials for Stem Cell Bioengineering
Prewitz, M. C., Seib, F. P., Pompe, W., & Werner, C. (2012) · Macromolecular Rapid Communications · doi:10.1002/marc.201200382 · Cited by 51
Establishment of a novel human embryonic stem cell-derived trophoblastic spheroid implantation model
Lee, Y. L., Fong, S. W., Chen, A. C. H., Li, T., Yue, C., Lee, C., Ng, E. H. Y., Yeung, W. S. B., & Lee, C. (2015) · Human Reproduction · doi:10.1093/humrep/dev223 · Cited by 46
Nano-on-micro fibrous extracellular matrices for scalable expansion of human ES/iPS cells
Liu, L., Kamei, K., Yoshioka, M., Nakajima, M., Li, J., Fujimoto, N., Terada, S., Tokunaga, Y., Koyama, Y., Sato, H., et al. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.01.039 · Cited by 49
“The cells were seeded on a gelatin nanofibre matrix at 4 103 cells/cm2 in mTeSR1 cell culture medium (Stem Cell Technologies) [31] supplemented with 10 mM of the ROCK inhibitor Y27632 (Wako Chemicals) [32].”
InfluentialKohler, E. E., Cowan, C. E., Chatterjee, I., Malik, A. B., & Wary, K. K. (2010) · Blood · doi:10.1182/blood-2010-07-295261 · Cited by 51
Nishishita, N., Shikamura, M., Takenaka, C., Takada, N., Fusak, N., & Kawamata, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038389 · Cited by 49
“Several serum-free media were tested for their ability to support reprogramming of CD34+ CBCs on Pronectin F-coated dishes, including ReproFF (ReproCELL), ReproFF2 (ReproCELL), mTeSR1 (STEMCELL Technologies) [18], or the previously reported, chemically defined medium E8 [16].”
MethodFan, Y., Wu, J., Ashok, P., Hsiung, M., & Tzanakakis, E. S. (2015) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9544-x · Cited by 44
“For example, a defined medium based on DMEM/F12 with 100 ng/ml bFGF and components such as TGF-β, LiCl, insulin, GABA and BSA or human serum albumin (HSA) is extensively used in hPSC cultivation [51, 52].”
Gallego, M. J., Porayette, P., Kaltcheva, M. M., Bowen, R. L., Meethal, S. V., & Atwood, C. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt28 · Cited by 49
“Human embryonic stem cell culture Propagation of human embryonic stem cells Pluripotent H9 hESCs (passage 22 to 32; XX karyotype; also known as WA09, a National Institutes of Health registered line) were obtained from the WiCell Research Institute (Madison, WI).”
BackgroundInfluentialHuman Embryonic Stem Cell Lines Model Experimental Human Cytomegalovirus Latency
Penkert, R. R., & Kalejta, R. F. (2013) · mBio · doi:10.1128/mbio.00298-13 · Cited by 44
Fleischer, S., Jahnke, H., Fritsche, E., Girard, M., & Robitzki, A. A. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.10.061 · Cited by 48
Signaling Roadmap Modulating Naive and Primed Pluripotency
Hassani, S., Totonchi, M., Gourabi, H., Schöler, H. R., & Baharvand, H. (2013) · Stem Cells and Development · doi:10.1089/scd.2013.0368 · Cited by 51
“In a serum-and feeder-free culture condition, Activin was shown to be sufficient for the long-term maintenance of hESCs [90].”
Opening the black box: Stem cell–based modeling of human post-implantation development
Taniguchi, K., Heemskerk, I., & Gumucio, D. L. (2018) · The Journal of Cell Biology · doi:10.1083/jcb.201810084 · Cited by 46
“No additional signaling factors, such as BMP4, are added, although mTeSR1 does contain FGF2 and TGFβ1, sufficient to maintain pluripotency (Ludwig et al., 2006).”
BackgroundLiu, J., Liu, S., Gao, H., Han, L., Chu, X., Sheng, Y., Wang, Y., Shou, W., Liu, Y., Wan, J., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02082-4 · Cited by 45
Human-Induced Pluripotent Stem Cells Produced Under Xeno-Free Conditions
Ross, P. J., Suhr, S. T., Rodríguez, R. M. A., Chang, E.-A., Wang, K., Siripattarapravat, K., Ko, T., & Cibelli, J. B. (2009) · Stem Cells and Development · doi:10.1089/scd.2009.0459 · Cited by 46
“This resulted in the later adaptation of the system to the use of some animal components, making the medium more reliable and accessible but loosing its xeno-free characteristics [ 33 ].”
Chan, L. Y., Yim, E. K. F., & Choo, A. B. H. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0150 · Cited by 42
“These cells were enzymatically passaged with dispase, as previously described.(7)”
MethodSystematic optimization of human pluripotent stem cells media using Design of Experiments
Marinho, P. A., Chailangkarn, T., & Muotri, A. R. (2015) · Scientific Reports · doi:10.1038/srep09834 · Cited by 47
The march of pluripotent stem cells in cardiovascular regenerative medicine
Abou-Saleh, H., Zouein, F. A., EL‐Yazbi, A. F., Sanoudou, D., Raynaud, C. M., Rao, C., Pintus, G., Dehaini, H., & Eid, A. H. (2018) · Stem Cell Research & Therapy · doi:10.1186/s13287-018-0947-5 · Cited by 52
“Alternatively, matrigel-coated surfaces have also been utilized with promising results [187].”
BackgroundGenerating Human Organs via Interspecies Chimera Formation: Advances and Barriers.
Angeles, A. D. L., N, P. E. T. E. R. C. O. L. E. M. A., & Redmond, D. E. (2018) · PubMed Central · Cited by 57
Wang, L., Su, Y., Huang, C., Yin, Y., Chu, A., Knupp, A., & Tang, Y. (2019) · Biology Open · doi:10.1242/bio.047225 · Cited by 39
Optimization of Matrigel-based culture for expansion of neural stem cells
Lee, S.-W., Lee, H. J., Hwang, H. S., Ko, K., Han, D. W., & Ko, K. (2015) · Animal Cells and Systems · doi:10.1080/19768354.2015.1035750 · Cited by 41
Hudson, J. E., Mills, R. J., Frith, J. E., Brooke, G. P., Jaramillo-Ferrada, P., Wolvetang, E. J., & Cooper-White, J. J. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0497 · Cited by 45
“Taking these issues into consideration, we chose mTeSR (Stem Cell Technologies), which is a defined medium designed for embryonic stem cell expansion with a disclosed composition [29,30].”
Culture Conditions Affect Cardiac Differentiation Potential of Human Pluripotent Stem Cells
Ojala, M., Rajala, K., Pekkanen-Mattila, M., Miettinen, M., Huhtala, H., & Aalto‐Setälä, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048659 · Cited by 52
“In this study, we cultured hPSCs with three different culture methods: on MEF [1] and on SNL [31] feeder cell layers combined with conventional ko-SR and bFGF containing stem cell culture medium and on Matrigel with mTeSR1 medium [9], and evaluated the influence of the culture method on the cardiac differentiation pot…”
BackgroundMethodJiwlawat, N., Lynch, E. M., Napiwocki, B. N., Stempien, A., Ashton, R. S., Kamp, T. J., Crone, W. C., & Suzuki, M. (2019) · Biotechnology and Bioengineering · doi:10.1002/bit.27075 · Cited by 43
Kamei, K., Yoshioka, M., Terada, S., Tokunaga, Y., & Chen, Y. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0423-8 · Cited by 44
“For the medium, we modified mTeSR-1 defined medium (Ludwig et al. 2006) containing BMP-4 and bFGF (Fig.”
MethodGeneration of Regionally Specified Human Brain Organoids Resembling Thalamus Development
Xiang, Y., Çakır, B., & Park, I. (2020) · STAR Protocols · doi:10.1016/j.xpro.2019.100001 · Cited by 45
“Remove medium from the tube, and re-suspend the cells with 2 mLmTeSR1 medium. mTeSR1 me- diumwas developed for feeder-independent culture of hPSCs (Ludwig et al., 2006a, 2006b) and has been widely used. mTeSR1 medium is warmed up to room temperature (22 - 25 C) before use.”
MethodEnzyme-free Passage of Human Pluripotent Stem Cells by Controlling Divalent Cations
Ohnuma, K., 藤木, 彩., Yanagihara, K., Tachikawa, S., Hayashi, Y., Ito, Y., Onuma, Y., Chan, T., Michiue, T., Furue, M. K., et al. (2014) · Scientific Reports · doi:10.1038/srep04646 · Cited by 42
Marco, A. D., Vignone, D., Paz, O. G., Fini, I., Battista, M. R., Cellucci, A., Bracacel, E., Auciello, G., Veneziano, M., Khetarpal, V. K., et al. (2020) · Cells · doi:10.3390/cells9040994 · Cited by 40
“Cells were maintained on Matrigel (Corning from SigmaAldrich, Milan, Italy)-coated surfaces in mTeSR1 (STEMCELL Tech, Cambridge, UK), as previously described [13] and passaged with 1 mg/mL dispase (Thermo Fisher, Monza, Italy) roughly every four days for a maximum of 33 passages.”
MethodRobust Generation of Hemangioblastic Progenitors from Human Embryonic Stem Cells
Lu, S., Luo, C., Holton, K., Feng, Q., Ivanova, Y., & Lanza, R. (2008) · Regenerative Medicine · doi:10.2217/17460751.3.5.693 · Cited by 44
Sridhar, A., Ohlemacher, S. K., Langer, K. B., & Meyer, J. S. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0093 · Cited by 39
“Three mRNA-reprogrammed lines of hiPSCs (designated miPS-2, miPS-4,andmiPS-6)andthreeretroviral-reprogrammed celllines (designated riPS-1, riPS-2, and riPS-4) were maintained in the un-differentiated state, as previously described [14, 16, 49].”
Optical mapping discerns genome wide DNA methylation profiles
Ananiev, G. E., Goldstein, S., Runnheim, R., Forrest, D., Zhou, S., Potamousis, K. D., Churas, C. P., Bergendahl, V., Thomson, J. A., & Schwartz, D. C. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-68 · Cited by 41
“Human embryonic stem cell line H1 was cultured in a feeder cell independent media according to published protocol [47].”
MethodKakni, P., López‐Iglesias, C., Truckenmüller, R. K., Habibović, P., & Giselbrecht, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1102209 · Cited by 41
“The ES cell line was maintained in feeder-free conditions using mTESR1 (StemCell Technologies), and passaged onto Matrigel (Corning)-coated tissue culture dishes every 4–5 days (Ludwig et al., 2006).”
MethodJiang, X., Li, X., Fei, X., Shen, J., Chen, J., Guo, M., & Li, Y. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.04.006 · Cited by 51
“According to our previous studies, FOXA2 and SOX17 were not expressed in the ESC stage, when cells were not differentiated [11,39].”
ResultRivera-Ordaz, A., Peli, V., Manzini, P., Barilani, M., & Lazzari, L. (2021) · BioDrugs · doi:10.1007/s40259-021-00503-9 · Cited by 47
“These media and matrices evolved from more complex formulations containing undefined supplements of animal origin [101] to simpler ones, partly or completely chemically-defined, containing human-”
BackgroundCell-Based Therapies for Parkinson's Disease: Past, Present, and Future
Fitzpatrick, K. M., Raschke, J., & Emborg, M. E. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2654 · Cited by 38
“A new direction in ES technology came in the form of the development of feeder-independent culture methods (102) that negated the risk of inducing cross-species contamination if cells were used in humans.”
Vazquez‐Arango, P., Vowles, J., Browne, C., Hartfield, E. M., Fernandes, H. J. R., Mandefro, B., Sareen, D., James, W., Wade‐Martins, R., Cowley, S. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw711 · Cited by 40
“Cells were fixed for 10 min in 2% paraformaldehyde in PBS (Alfa Aesar), permeabilized in 100% methanol at −20◦C for at least 30 min before staining and acquisition on a FACS Calibur (Becton Dickinson), analyzed with FlowJo software. qRT-PCR was used to assess silencing of Retrovirusdelivered reprogramming genes, using…”
MethodZhang, C., Du, L., Pang, K., & Wu, X. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183303 · Cited by 41
Directed Differentiation of Human Pluripotent Stem Cells to Podocytes under Defined Conditions
Qian, T., Hernday, S. E., Bao, X., Olson, W. R., Panzer, S. E., Shusta, E. V., & Palecek, S. P. (2019) · Scientific Reports · doi:10.1038/s41598-019-39504-8 · Cited by 39
Modeling human hematopoietic cell development from pluripotent stem cells
Kardel, M., & Eaves, C. J. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2012.04.001 · Cited by 39
Lu, H.-E., Tsai, M., Yang, Y.-C., Yuan, C.-C., Wang, T., Lin, X., Tseng, C., & Hwang, S. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.017 · Cited by 39
Jing, R., Duncan, C. B., & Duncan, S. A. (2017) · Development · doi:10.1242/dev.146845 · Cited by 40
“, 2010c) were regularly tested for contamination and cultured in mTeSR medium (Ludwig et al., 2006) with 4 ng/ml zbFGF on an E-cadherin-IgG Fc fusion protein matrix (Nagaoka and Duncan, 2010) in 4% O2/5% CO2.”
MethodLynch, E. M., Semrad, T., Belsito, V. S., FitzGibbons, C., Reilly, M. L., Hayakawa, K., & Suzuki, M. (2019) · Disease Models & Mechanisms · doi:10.1242/dmm.039552 · Cited by 38
Livestock pluripotency is finally captured in vitro
Navarro, M., Soto, D. A., Pinzón-Arteaga, C. A., Wu, J., & Ross, P. J. (2019) · Reproduction Fertility and Development · doi:10.1071/rd19272 · Cited by 47
Fu, S., Bury, L. A. D., Eum, J., & Wynshaw-Boris, A. J. (2023) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2023.03.015 · Cited by 37
Harkness, L., Christiansen, H., Nehlin, J. O., Barington, T., Andersen, J., & Kassem, M. S. (2008) · Stem Cell Research · doi:10.1016/j.scr.2008.06.001 · Cited by 36
“, 2006; Sathananthan and Trounson, 2005) and that plating efficiency of hESC without a matrix or feeders is low (Ludwig et al., 2006).”
BackgroundLu, S., Kelley, T. D., Feng, Q., Chen, A., Reuveny, S., Lanza, R., & Oh, S. K. (2013) · Regenerative Medicine · doi:10.2217/rme.13.36 · Cited by 35
Lu, M., Kardel, M., O’Connor, M. D., & Eaves, C. J. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.05.007 · Cited by 41
Defining synthetic surfaces for human pluripotent stem cell culture
Lambshead, J., Meagher, L., O’Brien, C., & Laslett, A. L. (2013) · Cell Regeneration · doi:10.1186/2045-9769-2-7 · Cited by 40
“Combinations of collagens, fibronectin, laminins and vitronectin have been reported to support long-term culture of hPSCs in a few studies [15,80], although combining ECMPs in this way can be superfluous given the aforementioned abilities of single-ECMPs (especially vitronectin and laminin-511) to support hPSCs.”
BackgroundProtocol for directed differentiation of human pluripotent stem cells toward a hepatocyte fate
Cai, J. (2014) · StemBook · doi:10.3824/stembook.1.52.1 · Cited by 42
“Although the purchase of defined culture media can be prohibitively expensive, clearly described protocols for the production of cost-effective mTeSR1 have been published by others that are relatively easily incorporated into the laboratory (Ludwig et al., 2006b; Ludwig et al., 2006a).”
BackgroundMethodZhao, C., Lin, K., & Wang, X. (2020) · Applied Materials Today · doi:10.1016/j.apmt.2020.100614 · Cited by 38
Dynamic 3D culture: Models of chondrogenesis and endochondral ossification
Foster, N. C., Henstock, J. R., Reinwald, Y., & Haj, A. J. E. (2015) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21088 · Cited by 38
Spatiotemporal mosaic self-patterning of pluripotent stem cells using CRISPR interference
Libby, A. R. G., Joy, D. A., So, P.-L., Mandegar, M. A., Muncie, J. M., Mendoza-Camacho, F. N., Weaver, V. M., Conklin, B. R., & McDevitt, T. C. (2018) · eLife · doi:10.7554/elife.36045 · Cited by 34
Fu, X., Toh, W. S., Liu, H., Lü, K., Li, M., Hande, M. P., & Cao, T. (2009) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2009.0360 · Cited by 34
Human Stem Cells and Articular Cartilage Regeneration
Inui, A., Iwakura, T., & Reddi, A. H. (2012) · Cells · doi:10.3390/cells1040994 · Cited by 37
“were established for ES cells [103,104] and applied to iPS cell culture [105,106].”
MethodTherapeutic Potentials of Human Embryonic Stem Cells in Parkinson’s Disease
Newman, M. B., & Bakay, R. A. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.02.004 · Cited by 37
“ing conditions were too rigorous and may jeopardize the integrity of hESCs genome.(76,77) Whether or not the mi-”
BackgroundAdvances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes
Bliley, J. M., Stang, M. A., Behre, A., & Feinberg, A. W. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae014 · Cited by 44
Functional Assays for Human Embryonic Stem Cell Pluripotency
O’Connor, M. D., Kardel, M., & Eaves, C. J. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-962-8_4 · Cited by 34
Lee, S., Kim, J., Park, T. J., Shin, Y., Lee, S. Y., Han, Y., Kang, S., & Park, H.-S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.058 · Cited by 33
Yang, S., Harnish, E., Leeuw, T., Dietz, U. H., Batchelder, E. M., Wright, P. S., Peppard, J., August, P. R., Volle‐Challier, C., Bono, F., et al. (2012) · Protein & Cell · doi:10.1007/s13238-012-2107-5 · Cited by 37
Calcium signaling in human pluripotent stem cells
Apáti, Á., Berecz, T., & Sarkadi, B. (2016) · Cell Calcium · doi:10.1016/j.ceca.2016.01.005 · Cited by 38
Porayette, P., Gallego, M. J., Kaltcheva, M. M., Meethal, S. V., & Atwood, C. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.021 · Cited by 39
“presence of mTeSR1 media (WiCell Research Institute [18]).”
Netsrithong, R., García-Pérez, L., & Themeli, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1325209 · Cited by 44
“Chemically de fi ned, animal origin-free culture media (ex. mTeSR-AOF (103 – 105), StemFit AK02N (65, 106), Essential 8 (E8) (102, 107) (108), HIDEF-B8 (109) as well as cryopreservation media options are commercially available.”
BackgroundZhu, H., Liu, C., Sun, J., Li, M., & Hua, J. (2012) · Theriogenology · doi:10.1016/j.theriogenology.2012.01.019 · Cited by 32
Planello, A. C., Ji, J., Sharma, V., Singhania, R., Mbabaali, F., Müller, F., Alfaro, J. A., Bock, C., Carvalho, D. D. D., & Batada, N. N. (2014) · Cell Regeneration · doi:10.1186/2045-9769-3-4 · Cited by 37
“iPSCs were maintained on a Matrigel (BD Biosciences, Mississauga, ON) -coated plate in complete mTeSR1 medium (Stemcell Technologies, Vancouver, BC) as previously described [25].”
MethodKwok, C. T. D., Leung, M., Qin, J., Qin, Y., Wang, J., Lee, Y. L., & Yao, K. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.007 · Cited by 36
“, 2006), was cultured on plates coated with BD MatrigelTM hESC-qualified Matrix (BD Biosciences, USA) in mTeSRTM1 Maintenance Medium (STEMCELL Technologies, Canada) at 37 °C in 5% CO2 (Ludwig et al., 2006).”
MethodOvercoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies
Nath, S. C., Menendez, L., & Friedrich Ben-Nun, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316929 · Cited by 35
LINE1 and PRC2 control nucleolar organization and repression of the 8C state in human ESCs
Zhang, J., Ataei, L., Mittal, K., Wu, L. L., Caldwell, L., Huynh, L., Sarajideen, S., Tse, K. Y., Simon, M.-M., Mazid, M. A., et al. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.09.024 · Cited by 35
The tumorigenic potential of pluripotent stem cells: What can we do to minimize it?
Peterson, S. E., Garitaonandia, I., & Loring, J. F. (2016) · BioEssays · doi:10.1002/bies.201670915 · Cited by 37
Price, A., Huang, E. Y., Sebastiano, V., & Dunn, A. R. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.12.005 · Cited by 32
“punctate clusters of protein distributed randomly over the surface, indicative of the heterogeneous adsorption of diluted Matrigel from solution at concentrations sufficient for feeder-free pluripotent cell culture [39].”
BackgroundCeholski, D. K., Turnbull, I. C., Kong, C., Koplev, S., Mayourian, J., Gorski, P. A., Stillitano, F., Skodras, A., Nonnenmacher, M. E., Cohen, N., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.05.007 · Cited by 31
Xiao, Y., Amaral, T. F., Ross, P. J., Soto, D. A., Diffenderfer, K. E., Pankonin, A. R., Jeensuk, S., Tríbulo, P., & Hansen, P. J. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab075 · Cited by 32
“The basal medium was a custom mTeSR1 medium without transforming growth factorβ that has been used for hESC and mEpiSC culture [21, 40].”
MethodLiang, D., Zhang, Y., Han, J., Wang, W., Liu, Y., Li, J.-F., & Jiang, X. (2015) · Endocrine journal · doi:10.1507/endocrj.ej15-0186 · Cited by 27
Kamei, K., Koyama, Y., Tokunaga, Y., Mashimo, Y., Yoshioka, M., Fockenberg, C., Mosbergen, R., Korn, O., Wells, C. A., & Chen, Y. (2016) · Advanced Healthcare Materials · doi:10.1002/adhm.201600893 · Cited by 34
Self-Renewal and Scalability of Human Embryonic Stem Cells for Human Therapy
Fu, X., & Xu, Y. (2011) · Regenerative Medicine · doi:10.2217/rme.11.18 · Cited by 30
A two-stage perfusion fibrous bed bioreactor system for mass production of embryonic stem cells
Ouyang, A., & Yang, S. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.895 · Cited by 29
“3 Defi ned media Recent research has shown that basic fibroblast growth factors (bFGF) and other growth factors such as TGFβ 1, activin A, stem cell factors (SCF), LIF, thrombopoietin (TPO), Fms-like tyrosine kinase 3 ligand (Flt3L), insulinlike growth factor and heregulin-1 were beneficial for the maintenance of hESC…”
BackgroundLong‐term expansion of human induced pluripotent stem cells in a microcarrier‐based dynamic system
Badenes, S. M., Fernandes, T. G., Miranda, C. C., Pusch‐Klein, A., Haupt, S., Rodrigues, C. A. V., Diogo, M. M., Brüstle, O., & Cabral, J. M. S. (2016) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.5074 · Cited by 32
Metabolome Profiling of Partial and Fully Reprogrammed Induced Pluripotent Stem Cells
Park, S., Lee, S., Prasain, N., Bae, D., Kang, H., Ha, T., Kim, J. S., Hong, K.-S., Mantel, C., Moon, S., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0320 · Cited by 33
“Importantly, because culture conditions can influ-ence the metabolite composition within each cell population and variations can occur between cell lines, we maintained all cells in chemically defined medium (ie, mTeSR1) [21].”
Townshend, R. F., Shao, Y., Wang, S., Cortez, C. L., Esfahani, S. N., Spence, J. R., O'Shea, K. S., Fu, J., Gumucio, D. L., & Taniguchi, K. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.588941 · Cited by 33
Abraham, S., Sheridan, S. D., Miller, B. R., & Rao, R. R. (2010) · Biotechnology Progress · doi:10.1002/btpr.412 · Cited by 30
“In our culture system, the hPSCs were propagated in standard medium supplemented with 4 ng/mL of bFGF, as opposed to 50–100 ng/mL bFGF in other reported feeder-free systems that have used MEF-CM or more defined medium.(10,26,31) The minimal requirement of supplementation demonstrates the efficacy of the acellular subs…”
MethodStem Cell Therapy: A Hope for Dying Hearts
Sharma, R. B., & Raghubir, R. (2007) · Stem Cells and Development · doi:10.1089/scd.2006.0070 · Cited by 31
“Different strategies have been adopted to eliminate the use of mouse feeders and maintain the human ES cells in an undifferentiated state (59–66).”
Assessment of human pluripotent stem cells with PluriTest
Müller, F.-J., Brändl, B., & Loring, J. F. (2014) · StemBook · doi:10.3824/stembook.1.84.1 · Cited by 30
Liu, Y., Charles, L. F., Zarembinski, T. I., Johnson, K. I., Atzet, S. K., Wesselschmidt, R. L., Wight, M. E., & Kuhn, L. T. (2012) · Macromolecular Bioscience · doi:10.1002/mabi.201200043 · Cited by 30
Wahlin, K. J., Cheng, J., Jurlina, S. L., Jones, M. K., Dash, N., Ogata, A. R., Kibria, N., Ray, S. S., Eldred, K. C., Kim, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.764725 · Cited by 34
Trophoblast lineage cells derived from human induced pluripotent stem cells
Chen, Y., Wang, K., Chandramouli, G. V. R., Knott, J. G., & Leach, R. E. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.06.016 · Cited by 30
“bFGF is found to help maintain pluripotent status of ES cells through MEK/ERK signaling [20], while BMP4 facilitates trophoblast lineage differentiation combined with TGF-beta signaling [13].”
BackgroundRobust pluripotent stem cell expansion and cardiomyocyte differentiationviageometric patterning
Myers, F. B., Silver, J. S., Zhuge, Y., Beygui, R. E., Zarins, C. K., Lee, L. P., & Abilez, O. J. (2013) · Integrative Biology · doi:10.1039/c2ib20191g · Cited by 30
Selvakumar, D., Reyes, L., & Chong, J. J. H. (2022) · Current Cardiology Reports · doi:10.1007/s11886-022-01666-9 · Cited by 30
Hua, Y., Yoshimochi, K., Li, J., Takekita, K., Shimotsuma, M., Li, L., Qu, X., Zhang, J., Sawa, Y., Liu, L., et al. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-02879-z · Cited by 29
“However, considering that cells in AK02N and ON2 did not have the above abnormality under the same conditions, we speculate that the lower pluripotency of cells in E8 was related to the lack of albumin, which was in both AK02N and ON2 (Additional file 1: Table S1).”
BackgroundInfluentialEngineered Microenvironments for Self-Renewal and Musculoskeletal Differentiation of Stem Cells
Hwang, Y., Phadke, A., & Varghese, S. (2011) · Regenerative Medicine · doi:10.2217/rme.11.38 · Cited by 32
Modeling and correction of structural variations in patient-derived iPSCs using CRISPR/Cas9
Park, C., Sung, J. J., Choi, S.-H., Lee, D. R., Park, I., & Kim, D. (2016) · Nature Protocols · doi:10.1038/nprot.2016.129 · Cited by 31
In situ label-free quantification of human pluripotent stem cells with electrochemical potential
Yea, C., Jeong, H., Moon, S., Lee, M., Kim, K.-J., Choi, J., & Cha, H. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.038 · Cited by 28
“Therefore, hPSCs were maintained in chemically defined mTeSR1 medium under conventional feeder-free conditions as described previously [29] and were then subjected to measurement.”
MethodDevelopments in cell culture systems for human pluripotent stem cells
Liu, W., Deng, C., Godoy-Parejo, C., Zhang, Y., & Chen, G. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i11.968 · Cited by 32
Xie, Y., Yao, J., Jin, W., Ren, L., & Li, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.765980 · Cited by 36
“Compared with TeSR medium, the development of E8 medium rejects the animal derived bovine serum albumin and some non-essential additions, simplifying the medium components, maintaining the undifferentiated proliferation of ESCs, and further reducing the culture cost (Ludwig et al., 2006; Chen et al., 2011).”
MethodFunctional and Molecular Characterization of the Role of CTCF in Human Embryonic Stem Cell Biology
Balakrishnan, S. K., Witcher, M., Berggren, W. T., & Emerson, B. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042424 · Cited by 28
“with BMP4 to induce differentiation (differentiated hESCs) [20].”
BackgroundActivin Receptor Signaling Regulates Prostatic Epithelial Cell Adhesion and Viability
Simon, D. P., Meethal, S. V., Wilson, A. C., Gallego, M. J., Weinecke, S. L., Bruce, E. B., Lyons, P. F., Haasl, R. J., Bowen, R. L., & Atwood, C. (2009) · Neoplasia · doi:10.1593/neo.81544 · Cited by 27
“Indeed, the only other system examined to date assessing the hormonal requirements for cell proliferation in vitro has found that, under defined culture conditions, both a bFGF and a TGF-β family member are necessary for the proliferation of pluripotent human embryonic stem cells [53].”
Background
Metadata
- Authors
- Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A.
- Affiliations
- WiCell (US)
- University of Wisconsin–Madison (US)
- Corresponding author
- Ludwig, Tenneille E
- ORCID
- Thomson, James A
- Venue
- Nature Methods
- Published
- 2006-07-21
- Volume
- 3
- Issue
- 8
- Pages
- 637-646
- ISSN
- 1548-7091 (ISSN-L)
- 1548-7105
- OpenAlex
- W2006557127
- Cited by
- 681
- References
- 17
- Citations by year
- 2026: 13 · 2025: 19 · 2024: 27 · 2023: 19 · 2022: 23 · 2021: 34 · 2020: 33 · 2019: 27 · 2018: 30 · 2017: 33 · 2016: 39 · 2015: 40 · 2014: 40 · 2013: 46 · 2012: 57
- FWCI
- 12.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Methods (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Wisconsin Foundation
- National Institutes of Health (5r24rr017721-04)
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (R24-RR017721)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- human embryonic stem cells, defined culture medium, bovine serum albumin, Matrigel
- MeSH terms
- Cell Differentiation, Cell Line, Cell Survival, Culture Media, Humans, Stem Cells, Cell Culture Techniques, Tissue Engineering, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.